Chemotherapy News and Research

Latest Chemotherapy News and Research

Insight into the role of cancer stem cells in cancer initiation, progression and metastasis

Scientists have identified a distinct subpopulation of cancer stem cells (CSCs) that is responsible for metastasis of a deadly human pancreatic cancer.

13 Sep 2007

Uninsured community health center patients often have difficulty accessing specialty services

Uninsured patients in publicly funded community health centers face significant obstacles accessing specialty services outside of these centers, a new study finds.

12 Sep 2007

National effort to preserve, restore fertility in women with cancer

The Oregon National Primate Research Center and the Oregon Health & Science University School of Medicine have been named to a national team of institutions hoping to preserve or restore fertility in women battling cancer.

12 Sep 2007

Customized virus kills brain tumor stem cells that drive lethal cancer

A tailored virus destroys brain tumor stem cells that resist other therapies and cause lethal re-growth of cancer after surgery, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in the Sept. 18 edition of the Journal of the National Cancer Institute.

12 Sep 2007

St. Jude follows outcomes of stem cell transplant survivors

Patient care at St. Jude doesn't stop when the child is cured. The end of successful therapy is the start of many years of follow-up care. This care is aimed at helping make the recovery process successful and preparing the family and hometown doctor for long-term complications that might arise from the disease or its treatment.

11 Sep 2007

Sanofi-aventis announces settlement of average wholesale price suits with DoJ relating to Anzemet

Sanofi-aventis announced today a civil settlement with the U.S. Department of Justice to resolve "Average Wholesale Price" (AWP) lawsuits under the federal False Claims Act relating to Anzemet(R) involving one of its predecessor companies, Aventis Pharmaceuticals Inc. (API).

11 Sep 2007

Eight things you need to know about ovarian cancer

Ovarian cancer doesn't get the kind of attention breast cancer gets. It's not as common, and because survival rates are poor, it does not produce an army of survivors to raise awareness.

11 Sep 2007

C-reactive protein shown to be a potential target for cancer treatment

Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer.

11 Sep 2007

Chemotherapy may be culprit for fatigue in breast cancer survivors

A new study finds that, compared to healthy women, breast cancer survivors reported more days of fatigue and more severe fatigue symptoms.

11 Sep 2007

Innovative liquid crystal technology offers promise of new drugs

A partnership between Kent State University, Summa Health System and IC-MedTech Inc. has yielded an innovative liquid crystal technology that offers the promise of new drugs which may more effectively manage cancer and other diseases.

10 Sep 2007

A molecular probe that may one day light up tumors while surgery is in progress

Researchers at the Stanford University School of Medicine have developed a molecular probe that sets aglow tumor cells within living animals. Their goal is to use the probe to improve the diagnosis and treatment of cancer and other diseases.

10 Sep 2007

Some with breast cancer stop taking aromatase inhibitors because of joint and muscle pain

More than 10 percent of women with breast cancer stopped taking a commonly prescribed drug because of joint and muscle pain, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

10 Sep 2007

Laser technology detects cancer by scanning surface veins

A new technology for cancer detection that eliminates the need for drawing blood has been developed by Purdue University researchers.

5 Sep 2007

Decitabine and interferon gamma show promise for ocular melanoma that has spread

A combination of two drugs shows promise in treating a rare and therapy-resistant type of melanoma that originates in the eye and spreads to other organs, according to a new study led by Duke University Comprehensive Cancer Center researchers.

5 Sep 2007

Exercise and yoga improves quality of life in women with early-stage breast cancer

Two studies report that exercise and yoga can help maintain and in some cases improve quality of life in women with early-stage breast cancer.

5 Sep 2007

Ardea Biosciences completes phase 1 trials of HIV drug RDEA806

Ardea Biosciences, Inc. has announced that it has successfully completed Phase 1 single-ascending-dose, multiple-ascending-dose, food-effect, and drug-interaction studies of RDEA806, a novel HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), in healthy volunteers.

5 Sep 2007

Oncolytics Biotech issued new U.S. patent

Oncolytics Biotech Inc. has announced that it has been granted U.S. Patent 7,264,798 entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus."

5 Sep 2007

Retinoblastoma tumor suppressor may predict chemotherapy effectiveness

A common molecular pathway could help physicians predict which lung cancer patients will benefit from chemotherapy drugs, according to new research from a multidisciplinary team at the University of Cincinnati (UC).

3 Sep 2007

Researchers look at malaria resistance to chloroquine

Funded by a $1.5 million grant from the National Institutes of Health (NIH), scientists at Binghamton University, State University of New York, hope to understand how the malaria parasite Plasmodium falciparum evolved resistance to the once-effective medication chloroquine.

3 Sep 2007